Manuel Dı́az

1.3k total citations
24 papers, 528 citations indexed

About

Manuel Dı́az is a scholar working on Infectious Diseases, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Manuel Dı́az has authored 24 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 10 papers in Epidemiology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Manuel Dı́az's work include Viral gastroenteritis research and epidemiology (9 papers), Viral Infections and Immunology Research (9 papers) and Respiratory viral infections research (6 papers). Manuel Dı́az is often cited by papers focused on Viral gastroenteritis research and epidemiology (9 papers), Viral Infections and Immunology Research (9 papers) and Respiratory viral infections research (6 papers). Manuel Dı́az collaborates with scholars based in Cuba, Switzerland and United States. Manuel Dı́az's co-authors include Alina Tejeda, Roland W. Sutter, Sonia Resik, Magilé Fonseca, Anthony Burton, Lai Heng Hung, Luís Sarmiento, Pedro Más Lago, Mauricio Landaverde and Martin Friede and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Manuel Dı́az

24 papers receiving 490 citations

Peers

Countries citing papers authored by Manuel Dı́az

Since Specialization

Citations

This map shows the geographic impact of Manuel Dı́az's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Dı́az with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Dı́az more than expected).

Fields of papers citing papers by Manuel Dı́az

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Dı́az. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Dı́az. The network helps show where Manuel Dı́az may publish in the future.

Co-authorship network of co-authors of Manuel Dı́az

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Dı́az. A scholar is included among the top collaborators of Manuel Dı́az based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Dı́az. Manuel Dı́az is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tropis needle-free injector for fractional-dose IPV administration: A pilot study for integration into routine immunization services in Cuba 2025 ·Vaccine ·Sonia Resik, (unknown), Alina Tejeda, Manuel Dı́az, (unknown), (unknown), (unknown), Mariano Rivero, Magilé Fonseca, Hong Liu, (unknown), (unknown), (unknown), Ondrej Mach	2
2	Cannabinoids for Acute Postoperative Pain Management: A Systematic Review and Meta‐Analysis of Clinical Trials 2025 ·European Journal of Pain ·(unknown), Manuel Dı́az, (unknown), (unknown), Jessie D. Trujillo, Ángel Vilches‐Arenas, Jorge Rojas	2
3	Immunogenicity of intramuscular fractional dose of inactivated poliovirus vaccine 2019 ·The Journal of Infectious Diseases ·Sonia Resik, Ondrej Mach, Alina Tejeda, Visalakshi Jeyaseelan, Magilé Fonseca, Manuel Dı́az, (unknown), Lai Heng Hung, (unknown), (unknown), (unknown), Roland W. Sutter	10
4	Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2? 2018 ·Clinical Infectious Diseases ·Sonia Resik, Alina Tejeda, Ondrej Mach, Magilé Fonseca, Manuel Dı́az, (unknown), Lai Heng Hung, (unknown), (unknown), (unknown), Roland W. Sutter	6
5	Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled Trial 2016 ·The Journal of Infectious Diseases ·Sonia Resik, Alina Tejeda, Manuel Dı́az, Hiromasa Okayasu, (unknown), Natalie A. Molodecky, Magilé Fonseca, (unknown), (unknown), Lai Heng Hung, (unknown), Roland W. Sutter	14
6	Decay of Sabin inactivated poliovirus vaccine (IPV)-boosted poliovirus antibodies 2015 ·PubMed ·Sonia Resik, Alina Tejeda, Magilé Fonseca, (unknown), Lai Heng Hung, (unknown), Manuel Dı́az, Hiromasa Okayasu, Roland W. Sutter	9
7	Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity 2015 ·Vaccine ·Sonia Resik, Alina Tejeda, Ondrej Mach, (unknown), Natalie A. Molodecky, Courtney Jarrahian, (unknown), Darin Zehrung, Magilé Fonseca, Manuel Dı́az, (unknown), (unknown), Lai Heng Hung, (unknown), Roland W. Sutter	31
8	Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: A randomized controlled trial in Cuba 2014 ·Vaccine ·Sonia Resik, Alina Tejeda, Ondrej Mach, Magilé Fonseca, Manuel Dı́az, (unknown), (unknown), Lai Heng Hung, (unknown), Roland W. Sutter	46
9	Reactogenicity and immunogenicity of inactivated poliovirus vaccine produced from Sabin strains: A phase I Trial in healthy adults in Cuba 2014 ·Vaccine ·Sonia Resik, Alina Tejeda, Magilé Fonseca, (unknown), Manuel Dı́az, (unknown), (unknown), Hiromasa Okayasu, Anthony Burton, Wilfried A.M. Bakker, Pauline Verdijk, Roland W. Sutter	17
10	Priming after a Fractional Dose of Inactivated Poliovirus Vaccine 2013 ·New England Journal of Medicine ·Sonia Resik, Alina Tejeda, Roland W. Sutter, Manuel Dı́az, Luís Sarmiento, (unknown), (unknown), Magilé Fonseca, Lai Heng Hung, Anna-Léa Kahn, Anthony Burton, (unknown), R. Bruce Aylward	105
11	Isolation and characterization of entomopathogenic bacteria from soil samples from the western region of Cuba 2013 ·Journal of Vector Ecology ·(unknown), (unknown), (unknown), Manuel Dı́az, (unknown), Zulema Menéndez Díaz, (unknown)	6
12	Evaluación de la respuesta humoral a la vacuna Heberbiovac HB en pacientes hemodializados de Ciudad de La Habana 2010 ·REVISTA BIOMÉDICA ·(unknown), Graciela Delgado, Manuel Dı́az, (unknown), (unknown), (unknown), (unknown), (unknown)	1
13	Randomized Controlled Clinical Trial of Fractional Doses of Inactivated Poliovirus Vaccine Administered Intradermally by Needle‐Free Device in Cuba 2010 ·The Journal of Infectious Diseases ·Sonia Resik, Alina Tejeda, Pedro Más Lago, Manuel Dı́az, (unknown), Luís Sarmiento, (unknown), (unknown), Anthony Burton, Martin Friede, Mauricio Landaverde, Roland W. Sutter	110
14	Characterization of Bacillus thuringiensis soil isolates from Cuba, with insecticidal activity against mosquitoes 2010 ·Revista de Biología Tropical ·(unknown), Raúl Dı́az, Manuel Dı́az, (unknown), (unknown), (unknown), (unknown)	11
15	Phase I Clinical Evaluation of a Synthetic Oligosaccharide-Protein Conjugate Vaccine against Haemophilus influenzae Type b in Human Adult Volunteers 2006 ·Clinical and Vaccine Immunology ·Gilda Toraño, María Eugenia Toledo, Alberto Baly, Violeta Fernández-Santana, F. Rodrı́guez, (unknown), Teresita Serrano, (unknown), (unknown), Eugenio Hardy, Arlene Rodríguez, Héctor Hernández‐Vargas, Arı́stides Aguilar, (unknown), Manuel Dı́az, Verena Muzio, (unknown), María C. Rodríguez, Lázaro Heynngnezz, Vicente Vérez-Bencomo	24
16	Selección de cepas atenuadas de Vibrio cholerae para la obtención de candidatos vacunales atenuados orales contra el cólera 2005 ·Revista cubana de medicina tropical ·(unknown), (unknown), Bárbara Cedré, (unknown), (unknown), Manuel Dı́az, (unknown), Arturo Talavera, Luis Garcı́a	2
17	Eficacia y seguridad de una vacuna contra la leptospirosis humana en Cuba 2004 ·Revista Panamericana de Salud Pública ·Raydel Martínez, Alberto Pérez, (unknown), (unknown), (unknown), (unknown), Carmen Fernández, (unknown), Islay Rodríguez, (unknown), Manuel Dı́az, José Rodríguez, Gustavo Sierra, (unknown), María Eugenia Toledo, Norma Fernández	50
18	Dengue, one of the great emerging health challenges of the 21st century 2004 ·Expert Review of Vaccines ·(unknown), G Kourí, Manuel Dı́az, Aliña Llop, Susana Vázquez, (unknown), Osvaldo Castro, (unknown), (unknown), (unknown), Harish Padmanabha, Beatríz Sierra, Ana Beatriz Alvarez Pérez, Delfina Rosario, Maritza Pupo, (unknown), Lizet Sánchez	36
19	Estudios postlicenciamiento de la vacuna cubana contra la hepatitis B, Heberbiovac-HB 2001 ·Biotecnología aplicada ·(unknown), (unknown), (unknown), (unknown), (unknown), Graciela Delgado, Manuel Dı́az, (unknown), (unknown), (unknown)	1
20	Safety and preliminary immunogenicity of the recombinant outer membrane protein P64k of Neisseria meningitidis in human volunteers 2001 ·Biotechnology and Applied Biochemistry ·Antonio Pérez, (unknown), (unknown), (unknown), Teresita Serrano, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Manuel Dı́az, (unknown), (unknown), (unknown), (unknown), A.M. Martin, (unknown), (unknown)	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact